HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: October 13 – 19, 2026

Posted In 340B

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Other

  • In a case challenging HRSA’s denial of a hospital’s request for retroactive 340B Disproportionate Share Hospital status, the federal government filed a reply in support of its motion to dismiss.
  • In a case brought by a drug manufacturer challenging a state law governing contract pharmacy arrangements, the plaintiff filed an appeal of the court’s order denying preliminary injunction.
  • In a case brought by a drug manufacturer challenging a state law governing contract pharmacy arrangements, the state government filed a reply in support of the state government’s motion to amend the court’s dismissal order.
  • In a case brought against a drug manufacturer under state law causes of action alleging the drug manufacturer is abusing its market power by denying plaintiff access to discounted pricing and violations against state consumer protection laws, the plaintiff filed a motion in opposition of the defendant drug manufacturer’s motion to dismiss.
  • In a case brought by a drug manufacturer challenging a Hawaii state law governing contract pharmacy arrangements, plaintiff filed a trial brief.
  • In a case brought by a trade association of drug manufacturers challenging a Hawaii state law governing contract pharmacy arrangements, plaintiff filed a reply in support of its motion for summary judgment.
Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Reuben Bank
Reuben Bank provides regulatory and transactional counseling on all aspects of state and federal healthcare laws impacting hospitals and healthcare systems.Learn more about Reuben's practice here.


Abygail Hoey
Abygail Hoey is a member of the Health & Life Sciences Practice Group, where she focuses her practice on healthcare transactions, as well as regulatory and compliance matters. Learn more about Abygail's practice here.


Deepika Raj
Deepika Raj advises a broad range of healthcare industry clients on regulatory, compliance and transactional matters. She offers multifaceted advice on state and federal fraud and abuse statutes, licensure rules, cannabis laws and due diligence matters. Learn more about Deepika's practice here.


Nadine Tejadilla
Nadine Tejadilla focuses her practice on transactional and regulatory matters in the health and life sciences industry. While in law school, Nadine served as a legal intern at a national nonprofit civil rights organization.Learn more about Nadine's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm